Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CardiolRx in Acute Myocarditis
NCT05180240Phase 2Completed
- Sponsor
- Cardiol Therapeutics Inc.
- Start
- Jul 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of cannabidiol in acute myocarditis, sponsored by Cardiol Therapeutics Inc.. Started Jul 2022; status: completed.
02
Drugs
cannabidiol
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on NCT05180240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05180240.